United Kingdom · Delayed Price · Currency is GBP · Price in GBX Trifast Earnings Call Transcripts
Fiscal Year 2026
-
FY26 brought further margin improvement, profit growth and cash generation while maintaining low leverage. Priorities include growth markets, India expansion and cyber preparedness; FY27 progress is expected in line with market expectations.
-
FY 2026 saw revenue decline but significant margin and cash improvements, driven by strategic exits from low-margin business and a pivot to higher-growth sectors. Strong cash flow enabled debt reduction and a higher dividend, with digital transformation and operational efficiency supporting future growth.
-
Gross and EBIT margins improved despite revenue declines and sector headwinds, driven by strategic focus on margin management, operational efficiency, and growth in smart infrastructure and medical equipment. Full-year guidance and double-digit margin ambition remain on track.
Fiscal Year 2025
-
First-half results showed improved margins and resilience amid tough macro conditions, with strong growth in smart infrastructure and medical equipment offsetting declines in automotive. Strategic execution, operational efficiencies, and disciplined capital allocation support confidence in meeting full-year and medium-term margin targets.
-
The meeting highlighted strong FY 2025 progress, with improved margins, efficiency savings, and a stable dividend. Strategic focus shifted toward high-growth sectors and technology investments, while all resolutions were approved. Key risks such as macroeconomic headwinds and cybersecurity were actively managed.
-
FY 2025 saw a 4.4% revenue decline but strong margin expansion, with EBIT up 30% and gross margin up 300 bps, driven by strategic initiatives and operational efficiencies. Despite macroeconomic headwinds and Q1 FY 2026 softness, the business remains confident in achieving double-digit EBIT margins.
-
H1 revenue was broadly flat as weak demand and low-margin customer exits were offset by improved margins: gross margin reached 27.4% and underlying EBIT margin was 6.2% at constant currency. Net debt and leverage improved, and FY 2025 delivery remains on track.
Fiscal Year 2024
-
FY 2024 saw lower revenue but improved EBIT margin and strong cash generation from inventory reduction, reducing net debt to £21m. Strategic focus is on margin management, operational efficiency, and growth in automotive, smart infrastructure, and medical equipment, with a medium-term goal of double-digit EBIT margins.